VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Harrow Health, Inc. (HROW) Total Return Calculator with Dividends Reinvested

Harrow Health, Inc.

Popular:

The total return for Harrow Health, Inc. (HROW) stock is +66.96% over the past 12 months. So far it's down 19.31% this year. The 5-year total return is +389.31%, meaning $10,000 invested in HROW stock 5 years ago would be worth $48,931 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in HROW 1 year ago, it would be worth $16,377 today — you'd have gained $6,377.

With Dividends Reinvested$16,377+63.77%

Price Only (No DRIP)$16,377+63.77%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in HROW

1Y$16,696+$6,696 (+67.0%)67.0% CAGR

3Y$14,751+$4,751 (+47.5%)13.8% CAGR

5Y$48,931+$38,931 (+389.3%)37.4% CAGR

10Y$108,838+$98,838 (+988.4%)27.0% CAGR

15Y$390,971+$380,971 (+3809.7%)27.7% CAGR

20Y$15,724+$5,724 (+57.2%)2.3% CAGR

30Y$15,724+$5,724 (+57.2%)1.5% CAGR

Harrow Health, Inc. did not pay dividends during this period. Total return = price return.

Loading HROW total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-19.31%	—	-19.31%	—	$8,069
1Y	+66.96%	66.96%	+66.96%	—	$16,696
3Y	+47.51%	13.83%	+47.51%	—	$14,751
5Y	+389.31%	37.38%	+389.31%	—	$48,931
10Y	+988.38%	26.96%	+988.38%	—	$108,838
15Y	+3809.71%	27.69%	+3809.71%	—	$390,971
20Y	+57.24%	2.29%	+57.24%	—	$15,724
30Y	+57.24%	1.52%	+57.24%	—	$15,724

Risk & Highlights

Best Year+228.90%2018

Worst Year-63.63%2008

Max Drawdown-39.27%2026-01-05 → 2026-03-20

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+8.56%	+8.56%	—	+0.41%	+8.1pp
2025	+34.03%	+34.03%	—	+16.64%	+17.4pp
2024	+180.75%	+180.75%	—	+24.00%	+156.8pp
2023	-24.22%	-24.22%	—	+24.81%	-49.0pp
2022	+70.44%	+70.44%	—	-19.95%	+90.4pp

HROW outperformed the S&P 500 by 35.63pp over the past year (+66.96% vs +31.32%).

Loading summary...

HROW Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
HROWHarrow Health, Inc.	$1.5B	+14.6%	-19.3%	+67.0%	—	+47.5%	+389.3%	+988.4%
PAHCPhibro Animal Health Corporation	$2.4B	+6.7%	+57.5%	+210.5%	+2.5pp	+318.1%	+136.4%	+207.3%
IMVTImmunovant, Inc.	$5.8B	+15.2%	+10.7%	+107.2%	—	+48.4%	+73.9%	+188.1%
NUVLNuvalent, Inc.	$6.9B	+0.5%	+3.4%	+52.9%	—	+176.1%	+456.1%	+456.1%
SGHTSight Sciences, Inc.	$232M	+21.1%	-42.5%	+53.0%	—	-59.1%	-87.2%	-87.2%
ICUIICU Medical, Inc.	$3.0B	-2.8%	-13.7%	-11.0%	—	-35.0%	-43.3%	+17.4%
ATRCAtriCure, Inc.	$1.4B	-4.0%	-28.7%	-6.2%	—	-41.4%	-64.0%	+100.6%
LNTHLantheus Holdings, Inc.	$5.6B	+13.5%	+28.1%	-17.8%	—	-9.1%	+290.0%	+4002.4%
PRGOPerrigo Company plc	$1.7B	+15.8%	-9.6%	-45.6%	+4.7pp	-56.6%	-58.6%	-76.8%
SUPNSupernus Pharmaceuticals, Inc.	$3.0B	+1.8%	+4.0%	+58.6%	—	+39.8%	+75.7%	+240.3%
MCKMcKesson Corporation	$91.1B	-13.2%	-9.6%	+5.0%	+0.4pp	+104.0%	+308.4%	+351.9%

Compare:HROW vs PAHC HROW vs IMVT HROW vs NUVL HROW vs PAHC vs IMVT

About HROW Dividend Returns

Harrow Health, Inc. (HROW) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of HROW over the past year?

Harrow Health, Inc. (HROW) delivered a return of 66.96% over the past year. Since HROW does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in HROW be worth today?

A $10,000 investment in Harrow Health, Inc. one year ago would be worth $16,696 today, representing a gain of $6,696.

Q3Does HROW pay dividends?

Harrow Health, Inc. (HROW) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For HROW, the total return equals the price-only return.

Q4Did HROW beat the S&P 500?

Yes, Harrow Health, Inc. (HROW) outperformed the S&P 500 by 35.63 percentage points over the past year. HROW delivered a total return of 66.96%, compared to the S&P 500's 31.32%. This 35.63pp alpha means investors in HROW earned more than a passive S&P 500 index fund.

Q5What is HROW's worst drawdown?

Harrow Health, Inc. (HROW) experienced a maximum drawdown of -39.27% over the past year, declining from its peak on 2026-01-05 to its trough on 2026-03-20. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is HROW's long-term total return over 10, 20, or 30 years?

Here are Harrow Health, Inc. (HROW)'s long-term returns with dividends reinvested. Over 10 years, the total return is 988.4% (27.0% CAGR) — $10,000 would have grown to $108,838. Over 20 years: 57.2% total return (2.3% CAGR) — $10,000 → $15,724. Over 30 years: 57.2% total return (1.5% CAGR) — $10,000 → $15,724. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was HROW's best and worst year?

Harrow Health, Inc.'s best calendar year was 2018 with a total return of 228.9%. Its worst year was 2008 with a total return of -63.6%. This range shows the volatility investors should expect — the difference between the best and worst year is 292.5 percentage points.